FDA wants to use children as guinea pigs for COVID-19 vaccines

An influential panel with the Food and Drug Administration voted unanimously to greenlight the approval of COVID-19 vaccines for children — not because children are at risk of falling seriously ill from the virus but because getting them vaccinated is the only way to determine the vaccines are actually necessary, according to one of the panelists.

During a meeting this week, the panel was asked an important question: “Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 vaccine when administered as a two-dose series outweigh its risks for use in children 5-11 years of age?”